Instalab
logoInstalab

Cat Dander IgE

Blood Test
A blood signal that cat exposure may be driving your sneezing, congestion, or asthma flares.
4.9 (4,448 reviews)
Tested by Quest or Genova
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Cat Dander IgE test?

This test is most useful if any of these apply to you.

Sneezing Around Cats
You suspect cats trigger your symptoms but want a clear answer about whether your immune system is genuinely reacting to them.
Managing Unexplained Asthma
Your asthma flares without obvious triggers, and you want to find out whether cat allergen is quietly driving the inflammation.
Living With a Cat
You share your home with a cat and want to know whether you are sensitized, and how strongly, before symptoms escalate.
Tracking a Child's Allergies
Your child has eczema, congestion, or wheezing, and you want to map out which allergens are involved before symptoms intensify with age.

About Cat Dander IgE

If you wheeze around cats, your eyes water at a friend's apartment, or your asthma flares for reasons you cannot pin down, this test gives you a direct biological answer. It measures whether your immune system has built specific antibodies against cat allergens, which is the underlying machinery that turns a cuddle with a tabby into a coughing fit.

What surprises most people is how often cat allergen turns up in places without cats. Schools, offices, and even cat-free homes can carry enough Fel d 1 (the dominant cat protein) to provoke symptoms in sensitized people, which is why the source of your symptoms is often invisible until you test for it.

What This Test Actually Measures

This test quantifies IgE (immunoglobulin E, the antibody class that drives classic allergic reactions) directed at proteins found in cat dander, saliva, and skin flakes. The dominant target is Fel d 1, a small protein produced mainly by cat sebaceous, salivary, lacrimal, and anal glands. Approximately 90 percent of cat-allergic patients have IgE to Fel d 1, which is why a positive cat dander IgE test usually reflects Fel d 1 sensitization.

Results are typically reported in kU/L (a concentration unit for very small amounts of antibody) using the ImmunoCAP assay.

Asthma Risk and Severity

Cat dander IgE is one of the strongest individual antibody markers tied to asthma. In a Swedish population study of young adults, people with high-titer cat or dog dander IgE had substantially elevated odds of persistent, more severe asthma compared with those without detectable levels.

Higher titers predict more than just diagnosis. They track with worse symptoms, more frequent exacerbations, and greater medication needs. Even after accounting for sensitization to pollens and other allergens, IgE to Fel d 1 stayed independently linked to current asthma.

Rhinitis, Conjunctivitis, and Multi-Organ Allergy

Beyond the lungs, cat dander IgE drives the classic upper-airway and eye symptoms of allergy: chronic nasal congestion, sneezing, itchy eyes, and skin flares. Patients with IgE to multiple cat molecules (Fel d 1 plus Fel d 2, 4, or 7) tend to have more complex phenotypes, meaning they more often have rhinitis, asthma, conjunctivitis, and dermatitis at the same time.

In adults presenting for cat allergy evaluation, the cumulative load of IgE to multiple cat proteins correlates with how many organ systems are involved. A single Fel d 1 number tells you one thing; a broader molecular pattern tells you how widely the allergy is likely to express itself.

Childhood Sensitization and Future Disease

Birth cohort data show that early sensitization to multiple major risk molecules predicts adolescent allergic disease. In the European BAMSE/MeDALL study, children sensitized early to three or more of four major risk molecules (peanut Ara h 1, birch Bet v 1, cat Fel d 1, and grass Phl p 1) at age 4 had a very high probability (87 to 100 percent) of having asthma or rhinitis by age 16. Detecting sensitization in childhood gives a meaningful forecast of which kids are likely to carry symptoms forward.

The IgE Versus IgG4 Balance

Not every sensitized person becomes symptomatic. Some people with heavy lifelong cat exposure develop a pattern called modified Th2, in which they produce high levels of Fel d 1-specific IgG4 (a different antibody class that can block allergic activation) alongside their IgE. In teens with cats at home, a higher IgG4-to-IgE ratio was associated with lower asthma risk, while a low ratio signaled higher risk.

The evidence here is not uniform. Some adult community studies and a German birth cohort have found no protective effect of high IgG4 on symptoms or wheeze in IgE-sensitized individuals, so IgG4 should be read as one piece of context rather than a guaranteed shield. The same IgE number can still mean very different things depending on exposure history and the balance of blocking antibodies, which is one reason a single reading does not tell the whole story.

Reconciling the Paradox of Sensitization Without Symptoms

A substantial share of people with positive IgE tests for inhalant allergens have no clinical symptoms. This is not a contradiction. IgE measures sensitization, the immune system's recognition of an allergen. Whether that sensitization translates into symptoms depends on antibody concentration, the balance of blocking IgG4, how much allergen you actually encounter, and individual differences in mast cell and basophil reactivity. A positive result tells you the machinery is in place; your history tells you whether it is firing.

Why a Single Reading Is Not Enough

Cat dander IgE is not static. It changes with exposure patterns, age, and treatment. After moving in with a cat, levels can rise over months. After years of immunotherapy or allergen avoidance, they tend to drift downward. A single number captures a moment, while a trend captures what your immune system is actually doing over time.

A reasonable approach is to get a baseline, retest at 6 to 12 months if you are pursuing immunotherapy, changing your home environment, or trying to understand whether new symptoms are cat-related, and then track annually if you have ongoing allergic disease. Compare readings drawn under similar conditions (same lab, same assay) to make trends interpretable.

When Results Can Be Misleading

  • Cross-reactivity with alpha-Gal: in regions where parasitic infections or tick exposures are common, IgE to the carbohydrate alpha-Gal can bind to the sugar on cat IgA (Fel d 5) and produce a positive cat dander IgE result in someone who is not actually cat-allergic. Component testing for Fel d 1 resolves this. Modern ImmunoCAP cat dander assays (post-2010) shifted to dander-only preparations that have largely reduced this cross-reactivity issue, but it can still arise on older platforms or with certain reagents.
  • Very high total IgE: in people with extremely elevated total IgE from atopic dermatitis or parasitic infection, nonspecific binding can inflate specific IgE readings, mainly on older assay platforms.
  • Recent acute illness: drawing blood during an active infection or severe inflammatory event can shift immune profiles. Stable baseline conditions give more interpretable numbers.
  • Undetectable serum IgE despite skin reactivity: some people have tissue-bound IgE that drives real symptoms but is below the serum detection threshold, so a negative serum test does not always rule out clinical cat allergy.

What to Do With an Unexpected Result

If your cat dander IgE comes back high but you do not have symptoms, do not panic. Sensitization without symptoms is common and may stay quiet your whole life. Track exposure, watch for upper airway or skin signals, and consider retesting in a year. If you live with a cat and have symptoms, a high result helps explain them and supports a workup with an allergist.

If your number is high and you are symptomatic, consider companion testing: a Fel d 1 component IgE to confirm true cat allergy, broader aeroallergen panels (mite, dog, pollens) to identify polysensitization, and total IgE to put the result in context. An allergist can interpret these together and discuss options ranging from environmental control to allergen immunotherapy. If your symptoms are severe or include asthma, that conversation should happen sooner rather than later.

Who Should Consider Component Testing

Cat dander IgE is a strong screening test, but component-resolved diagnostics (testing for individual cat proteins like Fel d 1, Fel d 2, Fel d 4, and Fel d 7) sharpen the picture. People with complex symptoms, those considering immunotherapy, anyone with possible meat or pork cross-reactivity, and those in regions where alpha-Gal sensitization is common benefit most from drilling down to the component level.

What Moves This Biomarker

Evidence-backed interventions that affect your Cat Dander IgE level

↓ Decrease
Anti-Fel d 1 monoclonal antibody (REGN1908/1909)
This experimental injectable directly neutralizes the Fel d 1 protein, preventing it from binding to your IgE and triggering symptoms. A single subcutaneous dose protected against cat-induced lung function drops and rhinitis symptoms for weeks, allowing tolerance of several-fold higher allergen doses. Nasal Th2 cytokines (IL-4, IL-5, IL-13) dropped significantly. The drug does not lower your own cat IgE production, but it changes how that IgE behaves in your body.
MedicationStrong Evidence
↓ Decrease
Subcutaneous allergen immunotherapy with cat dander extract
This is the closest thing to a disease-modifying treatment for cat allergy. Over months to years, it gradually retrains your immune system, eventually lowering cat-specific IgE while raising blocking IgG4 antibodies. In a dose-ranging study using cat dander extract, higher maintenance doses significantly reduced skin test reactivity and raised cat-specific IgG4 within weeks, and suppressed Th2 cells that drive the allergic response. IgE shifts tend to lag behind clinical improvement, so the lab number may move slowly even when symptoms get better.
MedicationModerate Evidence
↕ Up & Down
Chronic high-level cat exposure from early life
Sustained heavy cat exposure can shift the immune response toward a modified Th2 pattern, raising both cat-specific IgE and IgG4 (the blocking antibody) over time. The IgE number itself often rises, but the higher IgG4 can blunt symptoms in some people. In a teen birth cohort, cat owners with high IgG4-to-IgE ratios to Fel d 1 had lower asthma risk, while low ratios in cat owners were significantly associated with asthma. Other studies in adults and a German birth cohort have not found the same protective effect, so outcomes vary by individual immune programming, not exposure dose alone.
LifestyleModerate Evidence
↓ Decrease
Fel d 1 peptide immunotherapy (Cat-PAD)
Short courses of synthetic Fel d 1 peptides reduce allergic symptoms by reprogramming T cells that drive the cat-specific response, but they produce minimal change in measured cat IgE levels. In a randomized trial, repeated injections over several months produced significantly lower symptom scores up to a year later compared with placebo, with no meaningful change in serum cat-specific IgE. The clinical benefit comes from altered T cell function rather than from IgE reduction.
MedicationModest Evidence

Frequently Asked Questions

References

11 studies
  1. Quantitative IgE Antibody Assays in Allergic Diseases
    Perzanowski MS, Ronmark E, Platts-mills TAE, Lundback BJournal of Allergy and Clinical Immunology2003
  2. Component-resolved Diagnosis in Cat Allergy
    Bjerg a, Winberg a, Berthold MPediatric Allergy and Immunology2015
  3. Anti-fel D 1 Monoclonal Antibody Therapy for Cat Allergy
    Orengo JM, Radin AR, Kamat VNature Communications2018
  4. Subcutaneous Immunotherapy With Cat Allergen Extract
    Nanda a, O'connor M, Anand MJournal of Allergy and Clinical Immunology2004
  5. Fel D 1 Peptide Immunotherapy Reduces Symptoms of Cat Allergy
    Patel D, Couroux P, Hickey PJournal of Allergy and Clinical Immunology2013